Conagra Brands (CAG) Q4 2024 (Q&A) earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 (Q&A) earnings summary
3 Feb, 2026Executive summary
Achieved steady volume improvement for three consecutive quarters, with share gains in Frozen and Snacks and strong brand investments despite a challenging consumer environment.
Gross margin expanded due to supply chain productivity, and the balance sheet was strengthened with a reduced net leverage ratio.
Fourth quarter net sales declined 2.3% to $2.9B; full year net sales decreased 1.8% to $12.1B.
Q4 reported operating margin was (19.1)% due to non-cash impairment; adjusted margin 14.8%.
Full year adjusted EPS was $2.67, down 3.6% year-over-year.
Financial highlights
Q4 organic net sales were $2,901M, down 2.4% YoY; FY24 organic net sales were $12,022M, down 2.1%.
Q4 adjusted gross margin was 27.6% (+62 bps YoY); FY24 adjusted gross margin was 27.7% (+58 bps YoY).
Q4 adjusted operating margin was 14.8%; FY24 adjusted operating margin was 16.0% (+34 bps YoY).
Free cash flow for FY24 was $1,628M, up 157% from FY23.
Q4 and full year results impacted by $957M in goodwill and brand impairment charges.
Outlook and guidance
FY25 organic net sales expected to be flat to down 1.5% versus FY24.
FY25 adjusted operating margin guidance is 15.6% to 15.8%.
FY25 adjusted EPS expected in the range of $2.60 to $2.65.
Free cash flow conversion targeted at ~90%; capital expenditures projected at ~$500M.
Q1 FY25 volumes and top line expected to be lowest, with sequential improvement through the year.
Latest events from Conagra Brands
- Growth, innovation, and digital focus drive strong results and reaffirm FY26 outlook.CAG
Consumer Analyst Group of New York Conference (CAGNY) 202617 Feb 2026 - Growth in frozen and snacks, innovation, and strong cash flow support a positive outlook.CAG
Consumer Analyst Group of New York Conference 20253 Feb 2026 - Margin expansion and share gains offset sales declines; outlook stable despite headwinds.CAG
Q4 2024 Prepared Remarks3 Feb 2026 - Adjusted EPS fell 19.7% as sales declined, but reported EPS rose on a tax benefit.CAG
Q1 2025 (Q&A)19 Jan 2026 - Adjusted EPS fell 19.7% as sales declined, but fiscal 2025 guidance was reaffirmed.CAG
Q1 2025 Prepared Remarks19 Jan 2026 - Organic growth and share gains offset margin pressures amid inflation and FX headwinds.CAG
Q2 2025 Prepared Remarks10 Jan 2026 - Organic net sales up 0.3% and adjusted EPS down 1.4% amid inflation and FX headwinds.CAG
Q2 2025 (Q&A)10 Jan 2026 - Q3 sales and profits fell, but FY25 guidance and deleveraging targets remain on track.CAG
Q3 2025 (Q&A)26 Dec 2025 - Q3 FY25 sales and profit fell, but market share and cash flow remained strong; guidance steady.CAG
Q3 2025 Prepared Remarks26 Dec 2025